Danielle Cooke
Concepts (507)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intracranial Arteriovenous Malformations | 26 | 2022 | 50 | 5.920 |
Why?
| | Embolization, Therapeutic | 28 | 2023 | 229 | 5.450 |
Why?
| | Intracranial Aneurysm | 20 | 2022 | 97 | 5.300 |
Why?
| | Endovascular Procedures | 23 | 2025 | 312 | 4.270 |
Why?
| | Subarachnoid Hemorrhage | 10 | 2022 | 66 | 2.300 |
Why?
| | Central Nervous System Vascular Malformations | 12 | 2025 | 25 | 2.300 |
Why?
| | Cerebral Angiography | 24 | 2024 | 109 | 2.260 |
Why?
| | Endothelial Cells | 8 | 2022 | 785 | 2.240 |
Why?
| | Stents | 11 | 2022 | 527 | 2.040 |
Why?
| | Stroke | 19 | 2023 | 1120 | 2.010 |
Why?
| | Biopsy | 7 | 2022 | 1129 | 1.980 |
Why?
| | Angiography, Digital Subtraction | 17 | 2025 | 44 | 1.870 |
Why?
| | Aneurysm, Ruptured | 7 | 2022 | 35 | 1.780 |
Why?
| | Arteriovenous Fistula | 8 | 2025 | 36 | 1.700 |
Why?
| | Tomography, X-Ray Computed | 19 | 2025 | 2691 | 1.450 |
Why?
| | Robotics | 3 | 2024 | 94 | 1.440 |
Why?
| | Intracranial Hemorrhages | 7 | 2022 | 85 | 1.170 |
Why?
| | Brain Ischemia | 10 | 2022 | 338 | 1.150 |
Why?
| | Basilar Artery | 2 | 2018 | 6 | 1.140 |
Why?
| | Retinoblastoma | 5 | 2023 | 32 | 1.100 |
Why?
| | Retinal Neoplasms | 4 | 2018 | 25 | 1.060 |
Why?
| | Fluoroscopy | 8 | 2018 | 154 | 1.060 |
Why?
| | Vasospasm, Intracranial | 6 | 2017 | 17 | 1.040 |
Why?
| | Feasibility Studies | 6 | 2022 | 956 | 0.990 |
Why?
| | Magnetic Resonance Imaging | 22 | 2025 | 3566 | 0.950 |
Why?
| | Neurosurgery | 2 | 2022 | 39 | 0.900 |
Why?
| | Humans | 147 | 2025 | 137585 | 0.870 |
Why?
| | Iliac Artery | 2 | 2014 | 55 | 0.870 |
Why?
| | Robotic Surgical Procedures | 2 | 2025 | 130 | 0.840 |
Why?
| | Phantoms, Imaging | 6 | 2018 | 152 | 0.830 |
Why?
| | Magnetic Resonance Imaging, Interventional | 6 | 2016 | 24 | 0.830 |
Why?
| | Radiography, Interventional | 5 | 2023 | 116 | 0.830 |
Why?
| | Vascular Malformations | 5 | 2022 | 52 | 0.810 |
Why?
| | Endothelium, Vascular | 3 | 2019 | 927 | 0.800 |
Why?
| | Brain | 17 | 2025 | 2668 | 0.800 |
Why?
| | Radiosurgery | 8 | 2022 | 344 | 0.790 |
Why?
| | Cerebral Hemorrhage | 7 | 2022 | 108 | 0.790 |
Why?
| | Thrombectomy | 8 | 2022 | 69 | 0.780 |
Why?
| | Stroke Rehabilitation | 1 | 2023 | 42 | 0.780 |
Why?
| | Aneurysm | 3 | 2021 | 31 | 0.780 |
Why?
| | Software | 4 | 2020 | 665 | 0.770 |
Why?
| | Retrospective Studies | 57 | 2025 | 15657 | 0.760 |
Why?
| | Middle Aged | 62 | 2025 | 33479 | 0.730 |
Why?
| | Carotid Stenosis | 1 | 2022 | 91 | 0.700 |
Why?
| | Male | 83 | 2025 | 67762 | 0.690 |
Why?
| | Cerebral Arteries | 4 | 2017 | 59 | 0.690 |
Why?
| | Magnetic Resonance Angiography | 6 | 2020 | 240 | 0.680 |
Why?
| | Neuroimaging | 6 | 2025 | 259 | 0.670 |
Why?
| | Balloon Occlusion | 1 | 2020 | 34 | 0.670 |
Why?
| | Central Nervous System Diseases | 1 | 2021 | 69 | 0.660 |
Why?
| | Veins | 3 | 2022 | 63 | 0.650 |
Why?
| | Vascular Access Devices | 3 | 2018 | 26 | 0.650 |
Why?
| | Carotid Artery, Common | 1 | 2020 | 36 | 0.640 |
Why?
| | Cerebral Veins | 3 | 2021 | 16 | 0.640 |
Why?
| | Melphalan | 3 | 2018 | 35 | 0.610 |
Why?
| | Treatment Outcome | 33 | 2023 | 10811 | 0.610 |
Why?
| | Catheterization, Peripheral | 3 | 2016 | 109 | 0.610 |
Why?
| | Needles | 2 | 2018 | 59 | 0.600 |
Why?
| | Transcranial Magnetic Stimulation | 5 | 2020 | 60 | 0.590 |
Why?
| | Arteriovenous Shunt, Surgical | 1 | 2018 | 18 | 0.590 |
Why?
| | Female | 81 | 2025 | 73304 | 0.580 |
Why?
| | Graft Occlusion, Vascular | 1 | 2018 | 40 | 0.580 |
Why?
| | Wounds, Stab | 1 | 2018 | 13 | 0.580 |
Why?
| | Aged | 47 | 2025 | 23961 | 0.570 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2022 | 463 | 0.570 |
Why?
| | Jugular Veins | 1 | 2018 | 41 | 0.570 |
Why?
| | Neck Injuries | 1 | 2018 | 21 | 0.560 |
Why?
| | Nerve Net | 5 | 2020 | 256 | 0.540 |
Why?
| | Aorta, Thoracic | 1 | 2020 | 267 | 0.540 |
Why?
| | Obsessive-Compulsive Disorder | 3 | 2023 | 46 | 0.540 |
Why?
| | Lymphatic Abnormalities | 3 | 2022 | 19 | 0.530 |
Why?
| | Adult | 49 | 2025 | 37929 | 0.500 |
Why?
| | Angioplasty | 3 | 2022 | 47 | 0.480 |
Why?
| | Vertebrobasilar Insufficiency | 1 | 2015 | 8 | 0.470 |
Why?
| | Orbital Diseases | 2 | 2018 | 32 | 0.470 |
Why?
| | Disease Management | 3 | 2017 | 628 | 0.460 |
Why?
| | Tissue and Organ Harvesting | 1 | 2015 | 70 | 0.450 |
Why?
| | Renal Dialysis | 1 | 2018 | 435 | 0.440 |
Why?
| | Magnetic Fields | 2 | 2014 | 24 | 0.430 |
Why?
| | Neural Pathways | 4 | 2020 | 295 | 0.430 |
Why?
| | Spinal Cord | 4 | 2025 | 370 | 0.430 |
Why?
| | Image Interpretation, Computer-Assisted | 2 | 2020 | 267 | 0.420 |
Why?
| | Deep Brain Stimulation | 1 | 2015 | 153 | 0.400 |
Why?
| | Pitch Perception | 2 | 2025 | 9 | 0.400 |
Why?
| | Cerebral Infarction | 3 | 2025 | 44 | 0.390 |
Why?
| | Cell Separation | 1 | 2013 | 318 | 0.390 |
Why?
| | Mammary Arteries | 1 | 2012 | 7 | 0.390 |
Why?
| | Infusions, Intra-Arterial | 6 | 2018 | 59 | 0.390 |
Why?
| | Infarction, Middle Cerebral Artery | 2 | 2013 | 40 | 0.380 |
Why?
| | Vertebral Artery Dissection | 1 | 2012 | 24 | 0.380 |
Why?
| | Blood Vessel Prosthesis | 3 | 2019 | 127 | 0.380 |
Why?
| | Clinical Protocols | 3 | 2018 | 271 | 0.380 |
Why?
| | Catheters | 4 | 2017 | 73 | 0.370 |
Why?
| | Brain Neoplasms | 2 | 2025 | 1238 | 0.370 |
Why?
| | Sclerotherapy | 4 | 2022 | 20 | 0.360 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 3 | 2021 | 267 | 0.360 |
Why?
| | Radial Artery | 2 | 2021 | 68 | 0.350 |
Why?
| | Cochlear Implants | 2 | 2025 | 91 | 0.350 |
Why?
| | Temporal Arteries | 1 | 2011 | 45 | 0.350 |
Why?
| | Carotid Artery, Internal | 4 | 2019 | 42 | 0.340 |
Why?
| | Atherosclerosis | 1 | 2015 | 415 | 0.340 |
Why?
| | Transcriptome | 3 | 2022 | 971 | 0.330 |
Why?
| | Neuronavigation | 1 | 2010 | 7 | 0.330 |
Why?
| | Surgical Instruments | 1 | 2010 | 51 | 0.330 |
Why?
| | Ultrasonography, Doppler, Transcranial | 4 | 2017 | 45 | 0.320 |
Why?
| | Arteriovenous Malformations | 2 | 2020 | 27 | 0.320 |
Why?
| | Cardiac Catheterization | 1 | 2013 | 530 | 0.320 |
Why?
| | Carotid-Cavernous Sinus Fistula | 2 | 2019 | 9 | 0.310 |
Why?
| | MAP Kinase Signaling System | 2 | 2021 | 320 | 0.310 |
Why?
| | Aged, 80 and over | 13 | 2025 | 7635 | 0.300 |
Why?
| | Brain Mapping | 5 | 2020 | 503 | 0.290 |
Why?
| | Connectome | 5 | 2020 | 86 | 0.290 |
Why?
| | Cerebrovascular Circulation | 5 | 2022 | 243 | 0.290 |
Why?
| | Magnetics | 4 | 2016 | 48 | 0.290 |
Why?
| | Ophthalmic Artery | 2 | 2018 | 5 | 0.290 |
Why?
| | Vasodilator Agents | 1 | 2010 | 331 | 0.290 |
Why?
| | Foramen Magnum | 2 | 2021 | 10 | 0.280 |
Why?
| | Contrast Media | 4 | 2020 | 467 | 0.280 |
Why?
| | Cerebral Revascularization | 2 | 2020 | 19 | 0.270 |
Why?
| | Speech Perception | 2 | 2025 | 82 | 0.250 |
Why?
| | Young Adult | 17 | 2025 | 13209 | 0.250 |
Why?
| | Antineoplastic Agents, Alkylating | 2 | 2018 | 73 | 0.250 |
Why?
| | Cohort Studies | 11 | 2023 | 5742 | 0.240 |
Why?
| | Sclerosing Solutions | 3 | 2022 | 11 | 0.240 |
Why?
| | Child | 25 | 2023 | 21935 | 0.240 |
Why?
| | Preoperative Care | 3 | 2021 | 362 | 0.240 |
Why?
| | Cervical Vertebrae | 2 | 2025 | 137 | 0.240 |
Why?
| | Mutation | 6 | 2021 | 3958 | 0.230 |
Why?
| | Embolectomy | 2 | 2017 | 13 | 0.230 |
Why?
| | Meningioma | 2 | 2016 | 91 | 0.230 |
Why?
| | Catheterization | 2 | 2017 | 179 | 0.230 |
Why?
| | Equipment Design | 6 | 2025 | 522 | 0.230 |
Why?
| | Risk Factors | 9 | 2022 | 10388 | 0.230 |
Why?
| | Intracranial Arteriosclerosis | 2 | 2014 | 7 | 0.230 |
Why?
| | Infant | 13 | 2023 | 9465 | 0.220 |
Why?
| | Adolescent | 23 | 2025 | 21513 | 0.220 |
Why?
| | Perfusion Imaging | 3 | 2022 | 58 | 0.220 |
Why?
| | Mosaicism | 2 | 2021 | 73 | 0.210 |
Why?
| | Radiography | 4 | 2014 | 822 | 0.210 |
Why?
| | Microsurgery | 2 | 2021 | 75 | 0.210 |
Why?
| | Tomography, Emission-Computed, Single-Photon | 3 | 2011 | 80 | 0.210 |
Why?
| | Evoked Potentials, Motor | 2 | 2020 | 46 | 0.210 |
Why?
| | Imaging, Three-Dimensional | 3 | 2020 | 580 | 0.210 |
Why?
| | Computed Tomography Angiography | 3 | 2020 | 129 | 0.200 |
Why?
| | Swine | 6 | 2018 | 775 | 0.200 |
Why?
| | Implosive Therapy | 1 | 2023 | 42 | 0.200 |
Why?
| | Radiology, Interventional | 1 | 2023 | 33 | 0.200 |
Why?
| | Cerebral Cortex | 3 | 2022 | 433 | 0.200 |
Why?
| | Oxygen | 2 | 2025 | 931 | 0.190 |
Why?
| | Neurosurgical Procedures | 5 | 2022 | 197 | 0.190 |
Why?
| | Cochlear Implantation | 2 | 2025 | 76 | 0.190 |
Why?
| | Child, Preschool | 15 | 2021 | 11074 | 0.190 |
Why?
| | Flow Cytometry | 2 | 2017 | 1178 | 0.190 |
Why?
| | Machine Learning | 2 | 2024 | 493 | 0.190 |
Why?
| | Ventriculostomy | 2 | 2013 | 21 | 0.190 |
Why?
| | Giant Cell Arteritis | 1 | 2022 | 49 | 0.180 |
Why?
| | Polyarteritis Nodosa | 1 | 2021 | 6 | 0.180 |
Why?
| | Hematoma | 1 | 2021 | 53 | 0.180 |
Why?
| | Methamphetamine | 1 | 2022 | 63 | 0.180 |
Why?
| | Actins | 2 | 2013 | 416 | 0.180 |
Why?
| | Materials Testing | 2 | 2020 | 356 | 0.180 |
Why?
| | Combined Modality Therapy | 3 | 2016 | 1236 | 0.180 |
Why?
| | Angioplasty, Balloon | 1 | 2022 | 93 | 0.180 |
Why?
| | Cerebrovascular Disorders | 1 | 2022 | 96 | 0.180 |
Why?
| | Iodine Compounds | 1 | 2020 | 3 | 0.180 |
Why?
| | Receptor, Platelet-Derived Growth Factor beta | 1 | 2021 | 29 | 0.180 |
Why?
| | Gene Expression | 2 | 2017 | 1502 | 0.180 |
Why?
| | Precision Medicine | 1 | 2025 | 429 | 0.170 |
Why?
| | Moyamoya Disease | 1 | 2020 | 20 | 0.170 |
Why?
| | Brain Infarction | 1 | 2020 | 23 | 0.170 |
Why?
| | Surgery, Computer-Assisted | 2 | 2019 | 101 | 0.170 |
Why?
| | Growth Disorders | 1 | 2021 | 86 | 0.170 |
Why?
| | Nervous System Diseases | 2 | 2021 | 266 | 0.170 |
Why?
| | Observer Variation | 2 | 2020 | 343 | 0.170 |
Why?
| | Phenotype | 5 | 2021 | 3196 | 0.170 |
Why?
| | Spinal Cord Diseases | 1 | 2020 | 42 | 0.170 |
Why?
| | Blood Vessels | 1 | 2022 | 187 | 0.170 |
Why?
| | Recurrence | 3 | 2020 | 1060 | 0.170 |
Why?
| | Orbit | 2 | 2011 | 70 | 0.170 |
Why?
| | Telangiectasia, Hereditary Hemorrhagic | 1 | 2020 | 13 | 0.170 |
Why?
| | Models, Anatomic | 1 | 2020 | 93 | 0.170 |
Why?
| | Head Injuries, Penetrating | 1 | 2020 | 5 | 0.160 |
Why?
| | Calcium Channel Blockers | 2 | 2022 | 167 | 0.160 |
Why?
| | Multivariate Analysis | 3 | 2020 | 1509 | 0.160 |
Why?
| | Unconsciousness | 1 | 2020 | 19 | 0.160 |
Why?
| | Drug Administration Schedule | 1 | 2022 | 786 | 0.160 |
Why?
| | Equipment Failure Analysis | 2 | 2025 | 132 | 0.160 |
Why?
| | Printing, Three-Dimensional | 1 | 2020 | 95 | 0.160 |
Why?
| | Pyrimidinones | 1 | 2020 | 113 | 0.160 |
Why?
| | Mental Health Services | 1 | 2024 | 421 | 0.160 |
Why?
| | Mental Health | 2 | 2024 | 726 | 0.160 |
Why?
| | Torticollis | 1 | 2019 | 12 | 0.160 |
Why?
| | Amnesia | 1 | 2019 | 43 | 0.160 |
Why?
| | Follow-Up Studies | 9 | 2021 | 5131 | 0.160 |
Why?
| | Reproducibility of Results | 7 | 2020 | 3284 | 0.160 |
Why?
| | Polyvinyls | 2 | 2016 | 21 | 0.160 |
Why?
| | Brain Stem | 1 | 2020 | 94 | 0.150 |
Why?
| | Behavioral Symptoms | 1 | 2019 | 42 | 0.150 |
Why?
| | DCC Receptor | 1 | 2019 | 4 | 0.150 |
Why?
| | Dimethyl Sulfoxide | 2 | 2016 | 41 | 0.150 |
Why?
| | Electrocardiography | 3 | 1998 | 629 | 0.150 |
Why?
| | Models, Neurological | 1 | 2021 | 242 | 0.150 |
Why?
| | Blood Flow Velocity | 2 | 2017 | 413 | 0.150 |
Why?
| | Pyridones | 1 | 2020 | 168 | 0.150 |
Why?
| | Postoperative Hemorrhage | 1 | 2019 | 86 | 0.150 |
Why?
| | Prospective Studies | 10 | 2025 | 7604 | 0.150 |
Why?
| | Aspirin | 1 | 2022 | 387 | 0.150 |
Why?
| | Movement Disorders | 1 | 2019 | 58 | 0.150 |
Why?
| | Rabbits | 2 | 2022 | 794 | 0.150 |
Why?
| | Migraine Disorders | 1 | 2020 | 102 | 0.150 |
Why?
| | Family Health | 1 | 2019 | 196 | 0.150 |
Why?
| | Vascular Patency | 1 | 2018 | 106 | 0.150 |
Why?
| | Vascular Endothelial Growth Factor A | 2 | 2019 | 545 | 0.140 |
Why?
| | Blood-Brain Barrier | 1 | 2019 | 138 | 0.140 |
Why?
| | Cell Count | 1 | 2019 | 324 | 0.140 |
Why?
| | Plaque, Atherosclerotic | 1 | 2019 | 57 | 0.140 |
Why?
| | Retinal Vein | 1 | 2018 | 13 | 0.140 |
Why?
| | Vascular Diseases | 1 | 2021 | 243 | 0.140 |
Why?
| | Heterozygote | 1 | 2019 | 293 | 0.140 |
Why?
| | Receptor, TIE-1 | 1 | 2017 | 1 | 0.140 |
Why?
| | Diagnosis, Differential | 3 | 2017 | 1483 | 0.140 |
Why?
| | Endoglin | 1 | 2017 | 19 | 0.140 |
Why?
| | Matrix Metalloproteinase 2 | 1 | 2017 | 56 | 0.140 |
Why?
| | Memory | 1 | 2019 | 248 | 0.140 |
Why?
| | Gyrus Cinguli | 1 | 2017 | 86 | 0.140 |
Why?
| | Phlebography | 1 | 2017 | 38 | 0.140 |
Why?
| | Motivation | 1 | 2022 | 570 | 0.140 |
Why?
| | Diagnostic Errors | 1 | 2018 | 170 | 0.130 |
Why?
| | von Willebrand Factor | 1 | 2017 | 80 | 0.130 |
Why?
| | Radiographic Image Enhancement | 1 | 2017 | 58 | 0.130 |
Why?
| | Retinal Diseases | 1 | 2018 | 91 | 0.130 |
Why?
| | Infant, Newborn | 8 | 2023 | 6079 | 0.130 |
Why?
| | Depression | 3 | 2022 | 1397 | 0.130 |
Why?
| | Conscious Sedation | 1 | 2017 | 92 | 0.130 |
Why?
| | Microvessels | 1 | 2017 | 88 | 0.130 |
Why?
| | Workflow | 1 | 2017 | 165 | 0.130 |
Why?
| | Cardiac Surgical Procedures | 1 | 2022 | 530 | 0.130 |
Why?
| | Health Care Costs | 1 | 2019 | 398 | 0.130 |
Why?
| | Thalamus | 1 | 2017 | 107 | 0.120 |
Why?
| | Meningeal Arteries | 1 | 2015 | 2 | 0.120 |
Why?
| | Tantalum | 1 | 2015 | 3 | 0.120 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2017 | 153 | 0.120 |
Why?
| | Ferrous Compounds | 1 | 2015 | 23 | 0.120 |
Why?
| | Depressive Disorder | 1 | 2019 | 379 | 0.120 |
Why?
| | Carotid Arteries | 1 | 2017 | 206 | 0.120 |
Why?
| | Renal Artery | 1 | 2016 | 37 | 0.120 |
Why?
| | Quality Improvement | 1 | 2024 | 1178 | 0.120 |
Why?
| | Magnets | 1 | 2015 | 19 | 0.120 |
Why?
| | Time-to-Treatment | 1 | 2017 | 205 | 0.120 |
Why?
| | Hematoma, Subdural, Intracranial | 1 | 2015 | 1 | 0.120 |
Why?
| | American Heart Association | 1 | 2017 | 306 | 0.120 |
Why?
| | Filtration | 1 | 2015 | 72 | 0.120 |
Why?
| | Antineoplastic Agents | 2 | 2018 | 2129 | 0.120 |
Why?
| | Telemedicine | 1 | 2024 | 862 | 0.120 |
Why?
| | Ferric Compounds | 1 | 2015 | 56 | 0.120 |
Why?
| | Time Factors | 3 | 2022 | 6828 | 0.120 |
Why?
| | Aneurysm, False | 1 | 2015 | 48 | 0.120 |
Why?
| | Hearing Loss | 1 | 2019 | 221 | 0.120 |
Why?
| | Meningeal Neoplasms | 1 | 2016 | 100 | 0.120 |
Why?
| | Hemodynamics | 2 | 2017 | 1113 | 0.120 |
Why?
| | Gene Expression Profiling | 2 | 2022 | 1774 | 0.120 |
Why?
| | Genotype | 1 | 2020 | 1916 | 0.120 |
Why?
| | Collateral Circulation | 1 | 2015 | 19 | 0.120 |
Why?
| | Biopsy, Needle | 1 | 2015 | 189 | 0.110 |
Why?
| | Myocardial Infarction | 3 | 1998 | 1046 | 0.110 |
Why?
| | Laser Capture Microdissection | 1 | 2014 | 33 | 0.110 |
Why?
| | Intracranial Hypertension | 1 | 2015 | 40 | 0.110 |
Why?
| | Lasers | 1 | 2015 | 130 | 0.110 |
Why?
| | Radiotherapy Planning, Computer-Assisted | 1 | 2015 | 130 | 0.110 |
Why?
| | Drug Carriers | 1 | 2015 | 128 | 0.110 |
Why?
| | Prefrontal Cortex | 1 | 2017 | 301 | 0.110 |
Why?
| | Vein of Galen Malformations | 1 | 2014 | 2 | 0.110 |
Why?
| | DNA, Complementary | 1 | 2014 | 272 | 0.110 |
Why?
| | Protein Kinase Inhibitors | 1 | 2020 | 916 | 0.110 |
Why?
| | Decision Making | 2 | 2021 | 900 | 0.110 |
Why?
| | Magnetic Phenomena | 1 | 2014 | 10 | 0.110 |
Why?
| | Prognosis | 8 | 2017 | 4030 | 0.110 |
Why?
| | Severity of Illness Index | 1 | 2022 | 2828 | 0.110 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2014 | 346 | 0.110 |
Why?
| | Cerebral Arterial Diseases | 1 | 2013 | 47 | 0.110 |
Why?
| | Reference Values | 1 | 2015 | 816 | 0.110 |
Why?
| | Recovery of Function | 1 | 2018 | 653 | 0.110 |
Why?
| | Depressive Disorder, Major | 1 | 2017 | 364 | 0.110 |
Why?
| | Optical Imaging | 1 | 2014 | 64 | 0.100 |
Why?
| | Tungsten | 1 | 2013 | 30 | 0.100 |
Why?
| | Artifacts | 1 | 2014 | 129 | 0.100 |
Why?
| | Skin | 2 | 2017 | 752 | 0.100 |
Why?
| | Alloys | 1 | 2013 | 35 | 0.100 |
Why?
| | Ketones | 1 | 2013 | 49 | 0.100 |
Why?
| | Intracranial Thrombosis | 1 | 2012 | 17 | 0.100 |
Why?
| | Neck | 2 | 2023 | 101 | 0.100 |
Why?
| | Carboxypeptidases | 1 | 1992 | 13 | 0.100 |
Why?
| | Paresis | 1 | 2012 | 30 | 0.100 |
Why?
| | Comorbidity | 2 | 2014 | 1622 | 0.100 |
Why?
| | Radiation Dosage | 1 | 2014 | 179 | 0.100 |
Why?
| | Aorta, Abdominal | 1 | 2012 | 46 | 0.100 |
Why?
| | Animals | 9 | 2022 | 36940 | 0.090 |
Why?
| | Zygoma | 1 | 2011 | 8 | 0.090 |
Why?
| | Proteoglycans | 1 | 1992 | 107 | 0.090 |
Why?
| | Predictive Value of Tests | 5 | 2020 | 2031 | 0.090 |
Why?
| | Serine Endopeptidases | 1 | 1992 | 123 | 0.090 |
Why?
| | Cranial Sinuses | 2 | 2021 | 15 | 0.090 |
Why?
| | Cells, Cultured | 2 | 2022 | 4193 | 0.090 |
Why?
| | Peptide Hydrolases | 1 | 1992 | 111 | 0.090 |
Why?
| | Ethanol | 1 | 2015 | 608 | 0.090 |
Why?
| | RNA, Messenger | 1 | 2019 | 2833 | 0.090 |
Why?
| | Mast Cells | 1 | 1992 | 147 | 0.090 |
Why?
| | Health Personnel | 1 | 2017 | 710 | 0.090 |
Why?
| | Patient Admission | 1 | 2012 | 197 | 0.090 |
Why?
| | Parents | 1 | 2019 | 1347 | 0.090 |
Why?
| | Cerebral Ventriculography | 1 | 2010 | 3 | 0.080 |
Why?
| | Cell Survival | 1 | 2013 | 1120 | 0.080 |
Why?
| | Angiography | 3 | 2018 | 207 | 0.080 |
Why?
| | Hot Temperature | 1 | 2013 | 391 | 0.080 |
Why?
| | Echoencephalography | 1 | 2010 | 4 | 0.080 |
Why?
| | Organotechnetium Compounds | 1 | 2010 | 10 | 0.080 |
Why?
| | Cerebral Ventricles | 1 | 2010 | 52 | 0.080 |
Why?
| | Spinal Neoplasms | 1 | 2009 | 32 | 0.080 |
Why?
| | Quality of Life | 1 | 2022 | 2892 | 0.080 |
Why?
| | Emergency Medical Services | 1 | 1996 | 552 | 0.080 |
Why?
| | Anxiety Disorders | 2 | 2023 | 377 | 0.080 |
Why?
| | Datasets as Topic | 2 | 2020 | 121 | 0.080 |
Why?
| | Psychiatric Status Rating Scales | 2 | 2024 | 547 | 0.080 |
Why?
| | Muscle, Smooth, Vascular | 2 | 2022 | 446 | 0.080 |
Why?
| | Gene Expression Regulation | 1 | 2018 | 2607 | 0.080 |
Why?
| | Hydrocephalus | 1 | 2010 | 106 | 0.080 |
Why?
| | Functional Laterality | 2 | 2020 | 223 | 0.080 |
Why?
| | Sensitivity and Specificity | 4 | 2020 | 1946 | 0.070 |
Why?
| | Image Processing, Computer-Assisted | 3 | 2019 | 752 | 0.070 |
Why?
| | Cysteine | 1 | 2010 | 204 | 0.070 |
Why?
| | Rupture | 2 | 2020 | 92 | 0.070 |
Why?
| | Arteries | 2 | 2022 | 269 | 0.070 |
Why?
| | Constriction, Pathologic | 2 | 2022 | 245 | 0.070 |
Why?
| | RNA | 1 | 2014 | 921 | 0.070 |
Why?
| | ROC Curve | 2 | 2022 | 554 | 0.070 |
Why?
| | Polyethylene Glycols | 1 | 2013 | 641 | 0.070 |
Why?
| | Brain Injuries | 1 | 2013 | 494 | 0.070 |
Why?
| | Electromyography | 2 | 2020 | 400 | 0.070 |
Why?
| | Cerebellum | 2 | 2019 | 224 | 0.070 |
Why?
| | Registries | 1 | 2015 | 2035 | 0.070 |
Why?
| | Electronic Health Records | 2 | 2024 | 1069 | 0.060 |
Why?
| | Longitudinal Studies | 3 | 2025 | 2844 | 0.060 |
Why?
| | Case-Control Studies | 3 | 2019 | 3556 | 0.060 |
Why?
| | Injections, Intra-Arterial | 2 | 2015 | 27 | 0.060 |
Why?
| | Reperfusion | 1 | 2025 | 40 | 0.060 |
Why?
| | Atlases as Topic | 1 | 2025 | 10 | 0.060 |
Why?
| | Disease Models, Animal | 2 | 2015 | 4295 | 0.060 |
Why?
| | Anxiety | 2 | 2023 | 1035 | 0.060 |
Why?
| | Music | 1 | 2025 | 43 | 0.060 |
Why?
| | Regional Blood Flow | 2 | 2018 | 474 | 0.060 |
Why?
| | Patient Health Questionnaire | 1 | 2024 | 37 | 0.060 |
Why?
| | Surveys and Questionnaires | 3 | 2022 | 5778 | 0.050 |
Why?
| | Age Distribution | 2 | 2014 | 392 | 0.050 |
Why?
| | Camping | 1 | 2023 | 5 | 0.050 |
Why?
| | Phobic Disorders | 1 | 2023 | 33 | 0.050 |
Why?
| | Models, Animal | 2 | 2016 | 384 | 0.050 |
Why?
| | Hypertension | 1 | 2012 | 1295 | 0.050 |
Why?
| | Physician's Role | 1 | 2024 | 211 | 0.050 |
Why?
| | Doxycycline | 1 | 2022 | 62 | 0.050 |
Why?
| | Cross-Sectional Studies | 3 | 2022 | 5472 | 0.050 |
Why?
| | Pericytes | 1 | 2022 | 34 | 0.050 |
Why?
| | Psychiatry | 1 | 2024 | 180 | 0.050 |
Why?
| | Technology | 1 | 2022 | 96 | 0.050 |
Why?
| | Head | 1 | 2022 | 105 | 0.050 |
Why?
| | Age Factors | 2 | 2021 | 3295 | 0.040 |
Why?
| | Sodium | 1 | 2022 | 217 | 0.040 |
Why?
| | Skin Abnormalities | 1 | 2021 | 12 | 0.040 |
Why?
| | Aging, Premature | 1 | 2021 | 13 | 0.040 |
Why?
| | Mood Disorders | 1 | 2022 | 133 | 0.040 |
Why?
| | Intraoperative Period | 1 | 2021 | 59 | 0.040 |
Why?
| | Delayed Diagnosis | 1 | 2021 | 91 | 0.040 |
Why?
| | Intention | 1 | 2022 | 170 | 0.040 |
Why?
| | Survival Rate | 2 | 2014 | 1972 | 0.040 |
Why?
| | Headache | 1 | 2021 | 147 | 0.040 |
Why?
| | Vietnam Conflict | 1 | 2020 | 3 | 0.040 |
Why?
| | Minimally Invasive Surgical Procedures | 1 | 2021 | 179 | 0.040 |
Why?
| | Models, Theoretical | 2 | 2014 | 578 | 0.040 |
Why?
| | Coma | 1 | 2020 | 32 | 0.040 |
Why?
| | Germ-Line Mutation | 1 | 2021 | 172 | 0.040 |
Why?
| | Canada | 1 | 2021 | 418 | 0.040 |
Why?
| | Behavior Observation Techniques | 1 | 2019 | 10 | 0.040 |
Why?
| | Syndrome | 1 | 2020 | 358 | 0.040 |
Why?
| | Defense Mechanisms | 1 | 2019 | 23 | 0.040 |
Why?
| | Age of Onset | 1 | 2021 | 518 | 0.040 |
Why?
| | Neural Inhibition | 1 | 2020 | 169 | 0.040 |
Why?
| | Corneal Edema | 1 | 1999 | 4 | 0.040 |
Why?
| | Propensity Score | 1 | 2021 | 294 | 0.040 |
Why?
| | Carbonic Anhydrase Inhibitors | 1 | 1999 | 14 | 0.040 |
Why?
| | Visual Cortex | 1 | 2020 | 70 | 0.040 |
Why?
| | Refractive Errors | 1 | 1999 | 18 | 0.040 |
Why?
| | Gray Matter | 1 | 2020 | 80 | 0.040 |
Why?
| | Endothelium, Corneal | 1 | 1999 | 16 | 0.040 |
Why?
| | Fibroblasts | 2 | 2022 | 996 | 0.040 |
Why?
| | Diplopia | 1 | 2019 | 19 | 0.040 |
Why?
| | Basal Ganglia | 1 | 2019 | 56 | 0.040 |
Why?
| | Monocytes | 1 | 2022 | 563 | 0.040 |
Why?
| | Single-Cell Analysis | 1 | 2022 | 313 | 0.040 |
Why?
| | Costs and Cost Analysis | 1 | 2019 | 213 | 0.040 |
Why?
| | Functional Neuroimaging | 1 | 2019 | 55 | 0.040 |
Why?
| | Pyramidal Tracts | 1 | 2019 | 31 | 0.040 |
Why?
| | Cranial Nerve Diseases | 1 | 2019 | 42 | 0.040 |
Why?
| | Carotid Artery Diseases | 1 | 2019 | 64 | 0.040 |
Why?
| | Corpus Callosum | 1 | 2019 | 71 | 0.040 |
Why?
| | Motor Cortex | 1 | 2019 | 61 | 0.040 |
Why?
| | Cluster Analysis | 1 | 2020 | 499 | 0.040 |
Why?
| | Thiophenes | 1 | 1999 | 117 | 0.040 |
Why?
| | Symptom Assessment | 1 | 2019 | 128 | 0.040 |
Why?
| | Polymerase Chain Reaction | 1 | 2021 | 1062 | 0.040 |
Why?
| | Polytetrafluoroethylene | 1 | 1998 | 23 | 0.040 |
Why?
| | Paracentesis | 1 | 2018 | 14 | 0.040 |
Why?
| | Dermatologic Surgical Procedures | 1 | 1998 | 20 | 0.040 |
Why?
| | Problem Behavior | 1 | 2019 | 102 | 0.040 |
Why?
| | Groin | 1 | 2017 | 9 | 0.040 |
Why?
| | Anterior Cerebral Artery | 1 | 2017 | 5 | 0.040 |
Why?
| | Coronary Care Units | 1 | 1998 | 19 | 0.040 |
Why?
| | Punctures | 1 | 2017 | 40 | 0.040 |
Why?
| | Coronary Disease | 1 | 2000 | 385 | 0.040 |
Why?
| | Postoperative Complications | 2 | 2021 | 2654 | 0.030 |
Why?
| | Injections, Intravenous | 1 | 2018 | 206 | 0.030 |
Why?
| | Middle Cerebral Artery | 1 | 2017 | 53 | 0.030 |
Why?
| | Hemorrhage | 1 | 2022 | 722 | 0.030 |
Why?
| | Echocardiography | 1 | 2000 | 642 | 0.030 |
Why?
| | Analysis of Variance | 2 | 2000 | 1316 | 0.030 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2021 | 539 | 0.030 |
Why?
| | Random Allocation | 1 | 2018 | 353 | 0.030 |
Why?
| | Drug Delivery Systems | 1 | 2020 | 365 | 0.030 |
Why?
| | Carotid Artery, External | 1 | 2016 | 3 | 0.030 |
Why?
| | Ventricular Function, Left | 1 | 2000 | 534 | 0.030 |
Why?
| | Prostheses and Implants | 1 | 1998 | 143 | 0.030 |
Why?
| | Movement | 1 | 2019 | 278 | 0.030 |
Why?
| | Blood Volume | 1 | 2016 | 61 | 0.030 |
Why?
| | Parent-Child Relations | 1 | 2019 | 272 | 0.030 |
Why?
| | Amino Acid Sequence | 1 | 2020 | 2139 | 0.030 |
Why?
| | United States | 3 | 2021 | 14841 | 0.030 |
Why?
| | Gray Platelet Syndrome | 1 | 2015 | 3 | 0.030 |
Why?
| | Immunosuppressive Agents | 1 | 2021 | 890 | 0.030 |
Why?
| | Fibrous Dysplasia, Polyostotic | 1 | 2015 | 7 | 0.030 |
Why?
| | Genetic Variation | 1 | 2021 | 991 | 0.030 |
Why?
| | Mental Disorders | 1 | 2024 | 1077 | 0.030 |
Why?
| | Venous Pressure | 1 | 2015 | 8 | 0.030 |
Why?
| | Dexamethasone | 1 | 2018 | 368 | 0.030 |
Why?
| | Drug Compounding | 1 | 2015 | 101 | 0.030 |
Why?
| | Image Enhancement | 1 | 2016 | 190 | 0.030 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2016 | 389 | 0.030 |
Why?
| | Confidence Intervals | 1 | 1996 | 329 | 0.030 |
Why?
| | Sulfonamides | 1 | 1999 | 513 | 0.030 |
Why?
| | Sex Distribution | 1 | 1996 | 375 | 0.030 |
Why?
| | Diffusion | 1 | 2015 | 116 | 0.030 |
Why?
| | Models, Cardiovascular | 1 | 2015 | 198 | 0.030 |
Why?
| | Statistics as Topic | 1 | 2015 | 307 | 0.030 |
Why?
| | DNA | 1 | 2021 | 1459 | 0.030 |
Why?
| | Particle Size | 1 | 2015 | 394 | 0.030 |
Why?
| | Prevalence | 1 | 2021 | 2734 | 0.030 |
Why?
| | Perfusion | 1 | 2015 | 213 | 0.030 |
Why?
| | Multimodal Imaging | 1 | 2015 | 113 | 0.030 |
Why?
| | Mydriasis | 1 | 2013 | 10 | 0.030 |
Why?
| | Biocompatible Materials | 1 | 1998 | 425 | 0.030 |
Why?
| | Clinical Trials as Topic | 1 | 2018 | 1050 | 0.030 |
Why?
| | Causality | 1 | 2014 | 126 | 0.030 |
Why?
| | Electromagnetic Radiation | 1 | 2013 | 3 | 0.030 |
Why?
| | Pandemics | 1 | 2022 | 1639 | 0.030 |
Why?
| | Benzophenones | 1 | 2013 | 16 | 0.030 |
Why?
| | Tissue Distribution | 1 | 2014 | 332 | 0.030 |
Why?
| | Alzheimer Disease | 1 | 2019 | 560 | 0.030 |
Why?
| | Glucocorticoids | 1 | 2018 | 594 | 0.030 |
Why?
| | Amino Acid Substitution | 1 | 2013 | 307 | 0.020 |
Why?
| | Breast Neoplasms | 1 | 2025 | 2253 | 0.020 |
Why?
| | Chymases | 1 | 1992 | 4 | 0.020 |
Why?
| | California | 1 | 2014 | 431 | 0.020 |
Why?
| | Chromatography, Affinity | 1 | 1992 | 88 | 0.020 |
Why?
| | Chromatography, Gel | 1 | 1992 | 127 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2021 | 2426 | 0.020 |
Why?
| | Molecular Weight | 1 | 1992 | 335 | 0.020 |
Why?
| | Exocytosis | 1 | 1992 | 89 | 0.020 |
Why?
| | Inflammation | 1 | 2022 | 2837 | 0.020 |
Why?
| | Pilot Projects | 1 | 2016 | 1710 | 0.020 |
Why?
| | Muscle, Skeletal | 1 | 2020 | 1724 | 0.020 |
Why?
| | Pregnancy | 1 | 2022 | 6763 | 0.020 |
Why?
| | Polymers | 1 | 2013 | 490 | 0.020 |
Why?
| | Blood Loss, Surgical | 1 | 2009 | 101 | 0.020 |
Why?
| | Veterans | 1 | 2020 | 1476 | 0.020 |
Why?
| | Signal Transduction | 1 | 2021 | 5079 | 0.020 |
Why?
| | Disease Progression | 1 | 2015 | 2757 | 0.020 |
Why?
| | Carcinoma, Renal Cell | 1 | 2009 | 217 | 0.020 |
Why?
| | Incidence | 1 | 2014 | 2804 | 0.020 |
Why?
| | Databases, Factual | 1 | 2012 | 1357 | 0.020 |
Why?
| | Kidney Neoplasms | 1 | 2009 | 403 | 0.010 |
Why?
| | Technetium Tc 99m Sestamibi | 1 | 2000 | 14 | 0.010 |
Why?
| | Radiopharmaceuticals | 1 | 2000 | 178 | 0.010 |
Why?
| | Keratoplasty, Penetrating | 1 | 1999 | 4 | 0.010 |
Why?
| | Administration, Topical | 1 | 1999 | 151 | 0.010 |
Why?
| | Ophthalmic Solutions | 1 | 1999 | 75 | 0.010 |
Why?
| | Evaluation Studies as Topic | 1 | 1998 | 180 | 0.010 |
Why?
| | Swine, Miniature | 1 | 1998 | 82 | 0.010 |
Why?
| | Regression Analysis | 1 | 2000 | 1024 | 0.010 |
Why?
| | Equipment Failure | 1 | 1998 | 108 | 0.010 |
Why?
| | Electrodes | 1 | 1998 | 114 | 0.010 |
Why?
| | Angioplasty, Balloon, Coronary | 1 | 1998 | 141 | 0.010 |
Why?
| | Surface Properties | 1 | 1998 | 413 | 0.010 |
Why?
| | Intraocular Pressure | 1 | 1999 | 307 | 0.010 |
Why?
| | Visual Acuity | 1 | 1999 | 356 | 0.010 |
Why?
| | Lymphocytes | 1 | 1998 | 397 | 0.010 |
Why?
| | Glaucoma | 1 | 1999 | 237 | 0.010 |
Why?
| | Fibrinolytic Agents | 1 | 1998 | 270 | 0.010 |
Why?
| | Surgical Wound Infection | 1 | 1998 | 307 | 0.010 |
Why?
| | Heart Ventricles | 1 | 1998 | 788 | 0.010 |
Why?
| | Neutrophils | 1 | 1998 | 1238 | 0.010 |
Why?
|
|
Cooke's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|